Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 2873 entries
View as:

Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01432132 Org: User:
Start: 08/24/11 End: 07/25/17 Due: 07/25/18

Vibration Response Imaging (VRI) in Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00506467 Org: User:
Start: 11/30/06 End: 08/31/09 Due: 08/31/10

Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention

Phase: N/A Priority: Normal
NCT ID: NCT02422329 Org: User:
Start: 04/30/15 End: 03/07/18 Due: 03/07/19

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00501644 Org: User:
Start: 01/31/03 End: 01/31/09 Due: 01/31/10

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT03283917 Org: User:
Start: 02/07/18 End: 05/18/25 Due: 05/18/26

Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03417284 Org: User:
Start: 10/09/19 End: 07/18/24 Due: 07/18/25

Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00640978 Org: User:
Start: 03/31/08 End: 03/31/10 Due: 03/31/11

Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT00960544 Org: User:
Start: 01/31/19 End: 01/31/21 Due: 01/31/22

Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung Lesion

Phase: N/A Priority: Normal
NCT ID: NCT04995172 Org: User:
Start: 04/19/21 End: 11/27/24 Due: 11/27/25

Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00102661 Org: User:
Start: 10/31/02 End: 09/30/06 Due: 09/30/07

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03181100 Org: User:
Start: 07/27/17 End: 07/31/25 Due: 07/31/26

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06550050 Org: User:
Start: 10/31/24 End: 12/31/66 Due: 12/31/67

Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone

Phase: N/A Priority: Normal
NCT ID: NCT00059631 Org: User:
Start: 03/20/03 End: 06/17/15 Due: 06/17/16

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06383572 Org: User:
Start: 06/26/24 End: 04/01/29 Due: 04/01/30

Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions

Phase: N/A Priority: Normal
NCT ID: NCT05327270 Org: User:
Start: 09/13/22 End: 02/02/27 Due: 02/02/28

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Phase: N/A Priority: Normal
NCT ID: NCT05615636 Org: User:
Start: 04/28/23 End: 08/19/27 Due: 08/19/28

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Phase: N/A Priority: Normal
NCT ID: NCT00506857 Org: User:
Start: 11/30/03 End: 08/31/11 Due: 08/31/12

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01900002 Org: User:
Start: 09/13/13 End: 12/10/20 Due: 12/10/21

Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans

Phase: N/A Priority: Normal
NCT ID: NCT00476580 Org: User:
Start: 04/30/07 End: 08/31/15 Due: 08/31/16

Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS

Phase: N/A Priority: Normal
NCT ID: NCT00360438 Org: User:
Start: 07/31/06 End: 04/30/07 Due: 04/30/08

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00490282 Org: User:
Start: 06/30/07 End: 05/31/15 Due: 05/31/16

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

Phase: N/A Priority: Normal
NCT ID: NCT01751438 Org: User:
Start: 03/18/13 End: 04/19/23 Due: 04/19/24

Melatonin Postoperative Sleep Study in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00506064 Org: User:
Start: 02/29/04 End: 09/30/08 Due: 09/30/09

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT00715442 Org: User:
Start: 06/24/08 End: 12/04/26 Due: 12/04/27

Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00412594 Org: User:
Start: 06/10/04 End: 06/30/27 Due: 06/30/28